Variant report
Variant | esv3362401 |
---|---|
Chromosome Location | chr8:3841405-3841690 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183401262 | chr8:3841405-3841406 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2740805 | chr8:3841418-3841419 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs371342064 | chr8:3841433-3841434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374132897 | chr8:3841445-3841446 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556435067 | chr8:3841456-3841457 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs202178720 | chr8:3841457-3841458 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560549771 | chr8:3841460-3841461 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528118550 | chr8:3841464-3841465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546340340 | chr8:3841467-3841468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576731299 | chr8:3841469-3841470 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571322483 | chr8:3841471-3841472 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544288572 | chr8:3841474-3841475 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187525097 | chr8:3841476-3841477 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200545900 | chr8:3841477-3841478 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564204511 | chr8:3841486-3841487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536922165 | chr8:3841490-3841491 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555347339 | chr8:3841498-3841499 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566862784 | chr8:3841502-3841503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534207221 | chr8:3841503-3841504 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558731609 | chr8:3841506-3841507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577689163 | chr8:3841512-3841513 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs34824613 | chr8:3841516-3841517 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs199644891 | chr8:3841517-3841518 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539892900 | chr8:3841526-3841527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191460453 | chr8:3841528-3841529 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184662625 | chr8:3841540-3841541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113075011 | chr8:3841546-3841547 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542506145 | chr8:3841547-3841548 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187559394 | chr8:3841558-3841559 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78864192 | chr8:3841559-3841560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79341544 | chr8:3841560-3841561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549260279 | chr8:3841570-3841571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572462408 | chr8:3841577-3841578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112321950 | chr8:3841579-3841580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10094217 | chr8:3841583-3841584 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564794958 | chr8:3841584-3841585 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10103951 | chr8:3841587-3841588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532219309 | chr8:3841595-3841596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562310083 | chr8:3841598-3841599 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149942956 | chr8:3841600-3841601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370392041 | chr8:3841601-3841602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs200134065 | chr8:3841610-3841611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200843970 | chr8:3841612-3841613 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs201696080 | chr8:3841613-3841614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs386721174 | chr8:3841624-3841625 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10094057 | chr8:3841625-3841626 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79490532 | chr8:3841626-3841627 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs10094058 | chr8:3841629-3841630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs548858572 | chr8:3841630-3841631 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567171609 | chr8:3841635-3841636 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:3839400-3843000 | Weak transcription | HepG2 | liver |
2 | chr8:3841400-3841800 | Enhancers | Liver | Liver |